SCHEMBL173219

SCHEMBL173219

CC(C)(C)OC(=O)NC1Cc2ccccc2C1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.69
KDM1A O60341 1/20 0.53
MAOB P27338 1/20 0.53
DRD2 P14416 2/20 0.53
KMT2A Q03164 2/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
GRM7 Q14831 3/20 0.50
NAMPT P43490 1/20 0.49
MTNR1A P48039 1/20 0.49
MTNR1B P49286 1/20 0.49
MEN1 O00255 1/20 0.48
MAPT P10636 1/20 0.47
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
IDO1 P14902 1/20 0.47
NPC1 O15118 1/20 0.47
LMNA P02545 1/20 0.47
RAB9A P51151 1/20 0.47
BTK Q06187 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31694392 1.00 EPHX2 (0.69) EPHX2KDM1AMAOBDRD2KMT2A
SCHEMBL29565539 0.89 MTNR1A (0.66) EPHX2KDM1AMAOBDRD2KMT2A
SCHEMBL3682479 0.89 MTNR1A (0.66) EPHX2KDM1AMAOBDRD2KMT2A
SCHEMBL1015075 0.88 KDM1A (0.63) EPHX2KDM1AMAOBDRD2KMT2A
SCHEMBL1015074 0.88 KDM1A (0.63) EPHX2KDM1AMAOBDRD2KMT2A
SCHEMBL1015676 0.88 KDM1A (0.63) EPHX2KDM1AMAOBDRD2KMT2A
SCHEMBL29675257 0.85 EPHX2 (0.68) EPHX2KDM1AMAOBDRD2KMT2A
SCHEMBL22527375 0.85 EPHX2 (0.68) EPHX2KDM1AMAOBDRD2KMT2A
SCHEMBL28681707 0.85 EPHX2 (0.68) EPHX2KDM1AMAOBDRD2KMT2A
SCHEMBL6502466 0.84 MEN1 (0.55) EPHX2KMT2AGRM7MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114940700-A Phenyl propionamide derivative, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2022-08-26 CN disclosed
CN-114349820-A Phenyl propionamide derivative, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2022-04-15 CN disclosed
CN-108290926-B Phenyl propionamide derivative, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2022-02-08 CN disclosed
US-9918473-B2 Use of aryl carbamates in agriculture and other plant-related areas North Carolian State University (US) 2018-03-20 US disclosed
US-9918473-B2 Use of aryl carbamates in agriculture and other plant-related areas North Carolian State University (US) 2018-03-20 US disclosed
US-9918473-B2 Use of aryl carbamates in agriculture and other plant-related areas North Carolian State University (US) 2018-03-20 US disclosed
US-20160353739-A1 USE OF ARYL CARBAMATES IN AGRICULTURE AND OTHER PLANT-RELATED AREAS UNIV NORTH CAROLINA STATE (US) 2016-12-08 US disclosed
US-20160353739-A1 USE OF ARYL CARBAMATES IN AGRICULTURE AND OTHER PLANT-RELATED AREAS UNIV NORTH CAROLINA STATE (US) 2016-12-08 US disclosed
US-20160353739-A1 USE OF ARYL CARBAMATES IN AGRICULTURE AND OTHER PLANT-RELATED AREAS UNIV NORTH CAROLINA STATE (US) 2016-12-08 US disclosed
US-9439436-B2 Use of aryl carbamates in agriculture and other plant-related areas NORTH CAROLINA STATE UNIVERSITY (US) 2016-09-13 US disclosed
US-20130123225-A1 INHIBITION OF BACTERIAL BIOFILMS WITH ARYL CARBAMATES NORTH CAROLINA STATE UNIVERSITY 2013-05-16 US disclosed
US-20130123225-A1 INHIBITION OF BACTERIAL BIOFILMS WITH ARYL CARBAMATES NORTH CAROLINA STATE UNIVERSITY 2013-05-16 US disclosed
US-20130123225-A1 INHIBITION OF BACTERIAL BIOFILMS WITH ARYL CARBAMATES NORTH CAROLINA STATE UNIVERSITY 2013-05-16 US disclosed
WO-2012030986-A2 USE OF ARYL CARBAMATES IN AGRICULTURE AND OTHER PLANT-RELATED AREAS NORTH CAROLINA STATE UNIVERSITY (US) 2012-03-08 WO disclosed
WO-2012006276-A1 INHIBITION OF BACTERIAL BIOFILMS WITH ARYL CARBAMATES NORTH CAROLINA STATE UNIVERSITY (US) 2012-01-12 WO disclosed
WO-2012006276-A1 INHIBITION OF BACTERIAL BIOFILMS WITH ARYL CARBAMATES NORTH CAROLINA STATE UNIVERSITY (US) 2012-01-12 WO disclosed
WO-2011162562-A2 [6+5] FUSED BICYCLES AS A THROMBIN ANTAGONIST, PROCESS FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE BICYCLES KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2011-12-29 WO disclosed
CN-102056894-A Homocysteine synthase inhibitor MITSUBISHI TANABE PHARMA CORP 2011-05-11 CN disclosed
CN-101151245-A Indan-amide derivatives with glycogen phosphorylase inhibitory activity ASTRAZENECA AB (SE) 2008-03-26 CN disclosed
CN-101151267-A Chemical compounds ASTRAZENECA AB (SE) 2008-03-26 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160353739-A1 USE OF ARYL CARBAMATES IN AGRICULTURE AND OTHER PLANT-RELATED AREAS CTRC, ACE, DDT EPHX2 3148/4885KDM1A 65/4885MAOB 683/4885
US-20130123225-A1 INHIBITION OF BACTERIAL BIOFILMS WITH ARYL CARBAMATES PGLS, BLVRB, AADAC EPHX2 2216/4885KDM1A 30/4885MAOB 503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.